LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE Russian patent published in 2021 - IPC A61K31/198 A61K31/405 A61K38/48 A61K47/02 A61K47/18 A61K47/26 A61P5/00 A61P13/00 A61P19/02 A61P21/00 A61P25/00 A61P27/02 A61P29/00 A61Q19/08 

Abstract RU 2741497 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a liquid composition with botulinum neurotoxin protection against damage, comprising a botulinum neurotoxin, a surfactant, an amino acid selected from tryptophan and tyrosine, a buffer, including sodium ions, chloride ions and phosphate ions, where said liquid composition has pH value from 5.5 to 8, and where said composition does not contain animal proteins, and also relates to use of a liquid composition for treating or preventing muscular diseases, neuromuscular diseases, neurological diseases, ophthalmic diseases, pain conditions treatable by botulinum neurotoxin, psychological disorders, joint diseases, inflammatory diseases, endocrine disorders or urological diseases, also relates to use of a liquid composition in aesthetic medicine, and also relates to use of an amino acid selected from tryptophan and tyrosine, for botulinum neurotoxin protection against destruction in a liquid composition which does not contain animal proteins and contains a surfactant and a buffer containing sodium ions, chloride ions and phosphate ions, wherein said liquid composition has pH from 5.5 to 8.

EFFECT: group of inventions provides stability of composition for a long time.

23 cl, 10 tbl

Similar patents RU2741497C2

Title Year Author Number
PHARMACEUTICAL COMPOSITIONS OF CLOSTRIDIA TOXIN 2009
  • Dasari Gopal
  • Seneviratne Ananda
  • Ksi Dzhek Z.
  • Trehn Khuon T.
  • Prehs'Jut Aleks
  • Meht'Juson Don
  • Khant Terrens Dzhej
  • Kumar Khehrish P.M.
RU2535003C2
Liquid composition containing botulinum toxin and a stabilizing agent, and a method for its preparation 2017
  • Lee, Chee Gun
  • Oum, Ji Khyun
RU2748653C2
PEG-YLATED MUTANT TOXIN CLOSTRIDIUM BOTULINUM 2007
  • Frefert Jurgen
  • Shpekht Fol'Ker
RU2426739C2
NEUROTOXINS THAT DISPLAY REDUCED BIOLOGICAL ACTIVITY 2010
  • Khofmann Fred
  • Frefert Jurgen
RU2582266C2
NEUROTOXINS SHOWING SHORTENED BIOLOGICAL ACTIVITY 2012
  • Shmidt Mikhael
  • Frevert Yurgen
  • Khofmann Fred
  • Groer Gerkhard
RU2646110C2
THERAPEUTIC FUSION PROTEINS 2012
  • Cheddok Dzhon
  • Kharper Elejn
RU2651492C2
METHOD OF DETERMINING THE ACTIVITY OF BOTULINUM TOXIN USING CELLS 2019
  • Lee Chee Gun
  • Oum, Ji Hyun
  • Ajay, Vijayakumar
  • Gui Xiangai
RU2803123C2
IMPROVED USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA 2018
  • Chikosh, Yanosh
  • Pulte, Irena
  • Altkhaus, Mikhael
  • Kryuer, Markus
  • Vegener, Niko
RU2778481C2
DEVICES AND METHOD TO PRODUCE HIGHLY CLEANED NEUROTOXINS 2010
  • Pfajl' Mikhaehl'
  • Fridrikh Jozef
  • Tehjlor Kharol'D V.
  • Ajzele Karl-Khajnts
  • Brjunn Kornelija
RU2571212C2
LIQUID COMPOSITION STABILIZING BOTULINUM TOXIN 2019
  • Kim, Wanseop Paul
  • Kim, Yeong-Mok
  • Park, Gi-Sik
  • Park, Jae-Min
  • Lee, Ae-Yeon
RU2812790C2

RU 2 741 497 C2

Authors

Yarstad, Anders

Friis, Anna

Shtal, Ulf

Gurell, Ann

Agren, Barbro

Edstrom, Emiliya

Pikett, Endryu

Dates

2021-01-26Published

2017-05-26Filed